tobramycin inhaled
Selected indexed studies
- Bronchiectasis and inhaled tobramycin: A literature review. (Respir Med, 2022) [PMID:34998112]
- Inhaled tobramycin in non-cystic fibrosis bronchiectasis: A meta-analysis of randomized controlled trials. (Respir Med, 2025) [PMID:40339664]
- Inhaled tobramycin (TOBI). (Pediatr Nurs, 1998) [PMID:9987427]
_Worker-drafted node — pending editorial review._
Connections
tobramycin inhaled is a side effect of
Sources
- Inhaled tobramycin (TOBI). (1998) pubmed
- Immediate and Delayed Hypersensitivity Reactions to Antibiotics: Aminoglycosides, Clindamycin, Linezolid, and Metronidazole. (2022) pubmed
- Bronchiectasis and inhaled tobramycin: A literature review. (2022) pubmed
- Inhaled tobramycin in non-cystic fibrosis bronchiectasis: A meta-analysis of randomized controlled trials. (2025) pubmed
- Inhaled tobramycin for chronic infection with pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis: A systematic review and meta-analysis. (2021) pubmed
- Efficacy of adjunctive inhaled colistin and tobramycin for ventilator-associated pneumonia: systematic review and meta-analysis. (2024) pubmed
- Inhaled Tobramycin for Treatment of Ventilator-Associated Pneumonia: The Interplay of Patient, Drug, and Device. (2022) pubmed
- Use of inhaled tobramycin in cystic fibrosis. (2015) pubmed
- Inhaled tobramycin (TOBI): a review of its use in the management of Pseudomonas aeruginosa infections in patients with cystic fibrosis. (2003) pubmed
- [Inhaled tobramycin]. (2009) pubmed